Sunao Shoji, MD, PhD, MBA, presented “HIFU for Prostate Cancer in Asia” for the Grand Rounds in Urology audience in July, 2020.
HIFU for Prostate Cancer in Asia – Summary:
Sunao Shoji, MD, PhD, MBA, Associate Professor of Urology at Tokai University School of Medicine in Tokyo, Japan, discusses his institution’s study into using high-intensity focused ultrasound (HIFU) to treat localized prostate cancer in Asian men with Peter K.F. Chiu, Associate Consultant and Honorary Clinical Assistant Professor in the Prince of Wales Hospital at the Chinese University of Hong Kong. Dr. Shoji explains that HIFU is an attractive therapeutic modality for focal therapy of the prostate, since it aims to cure while preserving continence and erectile function. He describes his procedures for performing HIFU, including the use of MRI-TRUS elastic fusion image-guided prostate biopsy, and discusses the results of the study, observing that target lesions were changed to fibrosis in all patients, but that significant prostate cancer was detected in the untreated area in 8.9% of patients due to selection failures. Dr. Shoji theorizes that focal therapy using HIFU for localized prostate cancer for patients in Asia would have similar oncological and functional outcomes to those previously reported in Europe, but further large studies are required to verify the oncological and functional outcomes of this treatment.
Q&A – Summary:
Grand Rounds in Urology Associate Editor Peter K.F. Chiu, MD, PhD, FRCSEd, interviews Sunao Shoji, MD, PhD, MBA, Associate Professor of Urology at Tokai University School of Medicine in Tokyo, Japan, about Dr. Shoji’s presentation on high-intensity focused ultrasound (HIFU) for localized prostate cancer in Asian men. Topics covered include patient selection for HIFU, how many systematic biopsy cores should be taken before HIFU, whole gland treatment with HIFU, preventing the retention of urine after HIFU, and erectile dysfunction after HIFU.
For more educational content from our Asian Series, don’t miss Epidemiology & Genomics of Prostate Cancer in Asian Men with Dr. Yao Zhu.
How to cite: Shojiu, Sunao. “HIFU for Prostate Cancer in Asia” July, 2020. Accessed Nov 2024. https://grandroundsinurology.com/hifu-for-prostate-cancer-in-asia/
ABOUT THE AUTHOR
Sunao Shoji, MD, PhD, is an Associate Professor of Urology at Tokai University School of Medicine in Tokyo, Japan. He earned his medical degree from The School of Medicine of Tokyo Medical University. After becoming a certified urologist in Japan, he continued his training at the University of Southern California, Los Angeles, serving as a research fellow for 2 years. He has received numerous awards, including multiple recognitions for best abstract and video at the EAU and AUA, and he has recently received prestigious personal awards from the Japanese Urological Association and Japanese Society of Endourology. He specializes in minimally invasive surgery, and has performed more than 1100 MRI-Ultrasound fusion guided biopsies and more than 200 HIFU procedures for prostate cancer.
